Form 4: Intuitive Surgical SVP Sells Shares Under 10b5-1 Plan

Intuitive Surgical SVP Mark Brosius sold 3,658 shares of common stock across three transactions in early March 2026 under a pre-arranged trading plan.

Summary

• Mark Brosius, SVP & Chief Manufacturing and Supply Chain Officer at Intuitive Surgical Inc. (ISRG), reported sales of common stock.
• These transactions were conducted under a Rule 10b5-1 trading plan, which is set to expire on February 14, 2027.
• On March 3, 2026, 648 shares were sold at a weighted average price of $488.1, leaving 5,916 shares beneficially owned.
• On March 4, 2026, 2,362 shares were sold at a weighted average price of $498.6804, reducing beneficial ownership to 3,554 shares.
• On March 5, 2026, an additional 648 shares were sold at a weighted average price of $495.2, resulting in 2,906 shares beneficially owned.
• The total number of shares sold across these three dates is 3,658.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine disclosure of insider stock sales executed under a pre-established 10b5-1 trading plan, which is a common practice for executives.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those executed under a Rule 10b5-1 plan, are a routine aspect of executive compensation and personal financial management within the medical device and surgical robotics industry. These pre-arranged plans are designed to allow insiders to sell shares without concerns about trading on material non-public information.

Stakeholder Impact

• Shareholders may note the sale of common stock by a senior executive, although these transactions were pre-arranged under a Rule 10b5-1 trading plan, which is designed to avoid accusations of trading on material non-public information.

Key Dates

Keywords

Intuitive Surgical, ISRG, Insider Trading, Form 4, Stock Sale, Mark Brosius, 10b5-1 Plan